Aspire Biopharma Holdings, Inc.
ASBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847345
No open-market purchases or sales by Aspire Biopharma Holdings, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $250.9K in total; no superinvestor holds it.
Other share classesASBPW
13F holders, Q2 2024
Institutional positions in Aspire Biopharma Holdings, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 3
- −16 vs. Q1 2024
- Shares held
- 91.4K
- −1.55M (−94.4%) vs. Q1 2024
- Total value
- $90.4K
- −$18.0M (−99.5%) vs. Q1 2024
- New holders
- 1
- 1 more added
- Sold out
- 17
- 1 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ASBP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 13 | $250.9K |
| Q1 2026 | 15 | $371.9K |
| Q4 2025 | 30 | $899.8K |
| Q3 2025 | 25 | $645.6K |
| Q2 2025 | 16 | $544.7K |
| Q1 2025 | 15 | $875.8K |
| Q4 2024 | 3 | $5.36M |
| Q3 2024 | 2 | $149.6K |
| Q2 2024 | 3 | $90.4K |
| Q1 2024 | 19 | $18.1M |
| Q4 2023 | 21 | $17.9M |
| Q3 2023 | 21 | $18.2M |
| Q2 2023 | 14 | $17.0M |
| Q1 2023 | 59 | $267.9M |
| Q4 2022 | 57 | $264.7M |
| Q3 2022 | 61 | $260.8M |
| Q2 2022 | 54 | $243.4M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Aspire Biopharma Holdings, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Clear Street LLC | 7,247 | $81.7K | 0.00% | −43,530−85.7% | Reduced |
| UBS Group AG | 778 | $8.75K | 0.00% | +728+1,456.0% | Added |
| Crossingbridge Advisors, LLC | 83,333 | $0 | 0.00% | +83,333 | New |
| Fir Tree Capital Management LP | 0 | $0 | 0.00% | −212,815−100.0% | Sold out |
| Periscope Capital Inc. | 0 | $0 | 0.00% | −175,000−100.0% | Sold out |
| Arena Investors LP | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| CNH Partners LLC | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| Exos Asset Management LLC | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| Vivaldi Asset Management, LLC | 0 | $0 | 0.00% | −128,449−100.0% | Sold out |
| Cowen and Company, LLC | 0 | $0 | 0.00% | −117,717−100.0% | Sold out |
| First Pacific Advisors, LP | 0 | $0 | 0.00% | −56,966−100.0% | Sold out |
| Glazer Capital, LLC | 0 | $0 | 0.00% | −39,809−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −36,200−100.0% | Sold out |
| Westchester Capital Management, LLC | 0 | $0 | 0.00% | −36,029−100.0% | Sold out |
| Tuttle Tactical Management | 0 | $0 | 0.00% | −17,000−100.0% | Sold out |
| Robinson Capital Management, LLC | 0 | $0 | 0.00% | −10,162−100.0% | Sold out |
| Toroso Investments, LLC | 0 | $0 | 0.00% | −10,111−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −300−100.0% | Sold out |